Back to Search
DONNA COY, PHD
PHD
Medical Toxicology (Emergency Medicine) Physician
NPI: 1841945771Individual
Specialties, Licenses & Credentials
Medical Toxicology (Emergency Medicine) PhysicianPrimary
Emergency Medicine — Medical Toxicology
Code: 207PT0002X
4744(IL)
Research & Publications (20)
Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors.
PMID 19463875·Peptides·2009
7-preclinical
Reversible cytotoxic edema in a cirrhotic patient following TIPS.
PMID 19344367·J Neuroimaging·2009
5-case
Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas.
PMID 18795252·Diabetologia·2008
7-preclinical
Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor.
PMID 18006692·J Pharmacol Exp Ther·2008
4-observational
Involvement of VPAC1 and VPAC2 receptors in increasing local pancreatic blood flow in anesthetized rats.
PMID 18665096·Pancreas·2008
7-preclinical
Effects of camptothecin on tumor cell proliferation and angiogenesis when coupled to a bombesin analog used as a targeted delivery vector.
PMID 17264768·Anticancer Drugs·2007
8-other
A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
PMID 16644105·Cancer Lett·2007
7-preclinical
Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells.
PMID 17580098·Peptides·2007
7-preclinical
Identification of bombesin receptor subtype-specific ligands: effect of N-methyl scanning, truncation, substitution, and evaluation of putative reported selective ligands.
PMID 16943256·J Pharmacol Exp Ther·2006
7-preclinical
Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells.
PMID 16487413·Neurogastroenterol Motil·2006
8-other
Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase.
PMID 16613992·Mol Endocrinol·2006
8-other
In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors.
PMID 16766720·J Pharmacol Exp Ther·2006
7-preclinical
Somatostatin inhibits insulin release via SSTR2 in hamster clonal beta-cells and pancreatic islets.
PMID 15927701·Regul Pept·2005
7-preclinical
Development of simplified vasoactive intestinal peptide analogs with receptor selectivity and stability for human vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors.
PMID 15994369·J Pharmacol Exp Ther·2005
8-other
Camptothecin-somatostatin conjugates inhibit the growth of small cell lung cancer cells.
PMID 16112393·Peptides·2005
8-other
VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production.
PMID 15632701·Pancreas·2005
7-preclinical
Somatostatin-receptor 2 (sst2)-mediated effects of endogenous somatostatin on exocrine and endocrine secretion of the rat stomach.
PMID 15655503·Br J Pharmacol·2005
7-preclinical
Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP).
PMID 15670577·Biochem Pharmacol·2005
7-preclinical
Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3.
PMID 15102928·J Pharmacol Exp Ther·2004
7-preclinical
The effect of drug dose and drug exposure time on the binding, internalization, and cytotoxicity of radiolabeled somatostatin analogs.
PMID 15126075·J Surg Res·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2220 HICKS RD STE 240
ROLLING MEADOWS, IL 60008 - Phone
- (847) 401-7475
Quick Facts
- NPI
- 1841945771
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile